The Evira Study: Additional Support During Obesity Treatment
NCT: NCT06836284 · RECRUITING
Brief Summary
The goal of this clinical trial is to evaluate the effect of adding a digi-physical treatment tool as a complement to the local treatment with obesity medication in adolescents with obesity. The main question it aims to answer is: \- Can a combination of a digi-physical treatment tool and obesity medication improve treatment outcomes for patients with obesity compared to patients treated with obesity medications alone? This is a randomized controlled two-arm multicenter study where participants will be randomized to the intervention group (digi-physical treatment+medication) or control group (medication only). Participants will be followed for six months.
Frequently Asked Questions
What is The Evira Study: Additional Support During Obesity Treatment?
The Evira Study: Additional Support During Obesity Treatment is a clinical trial registered under NCT06836284. Current status: RECRUITING.
What is the status of NCT06836284?
The current status of NCT06836284 (The Evira Study: Additional Support During Obesity Treatment) is: RECRUITING.
When did The Evira Study: Additional Support During Obesity Treatment start?
The Evira Study: Additional Support During Obesity Treatment started on 2026-02-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.